Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZOHYDRO® ER safely and effectively. See full prescribing information for ZOHYDRO® ER. ZOHYDRO® ER (hydrocodone bitartrate) extended‑release capsules, for oral use, CII Initial U.S. Approval: 1943
Medication labelWhy this: Advisory · dailymed-prescription
ZOHYDRO® ER (hydrocodone bitartrate) is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations, reserve ZOHYDRO ER for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. ZOHYDRO ER is not indicated as an as-needed (prn) analgesic.
- generic_name
- hydrocodone bitartrate
- product_names
- hydrocodone bitartrate
- ndc
- 43376-310, 43376-315, 43376-320, 43376-330, 43376-340, 43376-350, 43376-310-60, 43376-315-60, 43376-320-60, 43376-330-60, 43376-340-60, 43376-350-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en